• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后原发性甲状旁腺功能亢进症患者循环 IL-17A 水平。

Circulating IL-17A Levels in Postmenopausal Women with Primary Hyperparathyroidism.

机构信息

Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.

Endocrinology and Diabetology Service, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.

出版信息

Mediators Inflamm. 2020 Jan 17;2020:3417329. doi: 10.1155/2020/3417329. eCollection 2020.

DOI:10.1155/2020/3417329
PMID:32256191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7099202/
Abstract

BACKGROUND

Primary hyperparathyroidism (PHPT) is a common cause of secondary osteoporosis in postmenopausal women. Th17 lymphocytes and the released cytokine IL-17A play an important role in bone metabolism. Th17 cells have been shown to be activated by PTH, and peripheral blood T cells from patients affected with PHPT express higher levels of IL-17A mRNA than controls.

AIM

To investigate circulating levels of IL-17A and the ratio RANKL/OPG, as markers of osteoclastogenesis, in 50 postmenopausal PHPT women compared with postmenopausal osteoporotic non-PHPT women ( = 20).

RESULTS

Circulating levels of IL-17A were similarly detectable in most PHPT and non-PHPT osteoporotic women (12.9 (8.4-23.1) vs. 11.3 (8.3-14.3) pg/ml, median (range interquartile), = 0.759), at variance with premenopausal women where IL-17A was undetectable. In PHPT women, any significant correlations could be detected between circulating IL-17A levels and PTH levels. Nonetheless, significant negative correlations between circulating IL-17A and ionized calcium levels ( = -0.294, = 0.047) and urine calcium excretions ( = -0.300, = 0.045) were found. Moreover, PHPT women were characterized by positive correlations between IL-17A levels and femur neck ( = 0.364, = 0.021) and total hip ( = 0.353, = 0.015) -scores. Circulating IL-17A levels did not show any significant correlation with sRANKL, OPG, and sRANKL/OPG ratio in PHPT women.

CONCLUSIONS

In postmenopausal PHPT women, circulating IL-17A levels were similar to those detected in postmenopausal non-PHPT women, showing a disruption of the relationship observed in postmenopausal osteoporosis among circulating PTH, sRANKL, OPG, IL-17A, and bone demineralization in postmenopausal PHPT women. The data support an osteogenic effect of IL-17A in postmenopausal PHPT women.

摘要

背景

原发性甲状旁腺功能亢进症(PHPT)是绝经后妇女继发性骨质疏松症的常见原因。Th17 淋巴细胞及其释放的细胞因子 IL-17A 在骨代谢中发挥重要作用。已经表明,甲状旁腺激素可以激活 Th17 细胞,并且患有 PHPT 的患者的外周血 T 细胞表达的 IL-17A mRNA 水平高于对照组。

目的

在 50 名绝经后 PHPT 女性与绝经后非 PHPT 骨质疏松症女性(= 20)相比,研究循环中 IL-17A 的水平以及作为破骨细胞生成标志物的 RANKL/OPG 比值。

结果

在大多数 PHPT 和非 PHPT 骨质疏松症女性中均可检测到循环 IL-17A 的水平(12.9(8.4-23.1)与 11.3(8.3-14.3)pg/ml,中位数(四分位间距范围),= 0.759),而在绝经前妇女中则无法检测到 IL-17A。在 PHPT 女性中,循环 IL-17A 水平与 PTH 水平之间没有发现任何显著相关性。尽管如此,仍发现循环 IL-17A 与离子钙水平(= -0.294,= 0.047)和尿钙排泄(= -0.300,= 0.045)之间存在显著负相关。此外,PHPT 女性的特点是 IL-17A 水平与股骨颈(= 0.364,= 0.021)和总髋部(= 0.353,= 0.015)评分之间呈正相关。PHPT 女性的循环 IL-17A 水平与 sRANKL、OPG 和 sRANKL/OPG 比值之间没有任何显著相关性。

结论

在绝经后 PHPT 女性中,循环 IL-17A 水平与绝经后非 PHPT 女性相似,表明在绝经后 PHPT 女性中,循环 PTH、sRANKL、OPG、IL-17A 和骨矿物质脱失之间的关系发生了中断。这些数据支持 IL-17A 在绝经后 PHPT 女性中的成骨作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3729/7099202/d67bb96dc819/MI2020-3417329.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3729/7099202/da1b85bc24f5/MI2020-3417329.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3729/7099202/567876ffdae3/MI2020-3417329.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3729/7099202/d67bb96dc819/MI2020-3417329.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3729/7099202/da1b85bc24f5/MI2020-3417329.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3729/7099202/567876ffdae3/MI2020-3417329.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3729/7099202/d67bb96dc819/MI2020-3417329.003.jpg

相似文献

1
Circulating IL-17A Levels in Postmenopausal Women with Primary Hyperparathyroidism.绝经后原发性甲状旁腺功能亢进症患者循环 IL-17A 水平。
Mediators Inflamm. 2020 Jan 17;2020:3417329. doi: 10.1155/2020/3417329. eCollection 2020.
2
The role of the receptor activator of nuclear factor-kappaB ligand/osteoprotegerin cytokine system in primary hyperparathyroidism.核因子-κB受体活化因子配体/骨保护素细胞因子系统在原发性甲状旁腺功能亢进症中的作用
J Clin Endocrinol Metab. 2008 Mar;93(3):967-73. doi: 10.1210/jc.2007-1645. Epub 2007 Dec 11.
3
Circulating fractures-related microRNAs distinguish primary hyperparathyroidism-related from estrogen withdrawal-related osteoporosis in postmenopausal osteoporotic women: A pilot study.循环骨折相关 microRNAs 可区分绝经后骨质疏松症妇女原发性甲状旁腺功能亢进症相关和雌激素缺乏相关骨质疏松症:一项初步研究。
Bone. 2020 Aug;137:115350. doi: 10.1016/j.bone.2020.115350. Epub 2020 May 5.
4
Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.测量老年女性骨代谢中核因子-κB 受体活化因子配体和骨保护素的可溶性受体的意义
Gerontology. 2009;55(3):275-80. doi: 10.1159/000196280. Epub 2009 Jan 22.
5
IL-17A-mediated sRANK ligand elevation involved in postmenopausal osteoporosis.白细胞介素-17A介导的可溶性核因子κB受体活化因子配体升高与绝经后骨质疏松症有关。
Osteoporos Int. 2014 Feb;25(2):783-6. doi: 10.1007/s00198-013-2548-6. Epub 2013 Dec 13.
6
Circulating profiles of osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand in post-menopausal women.绝经后女性骨保护素及可溶性核因子κB受体活化因子配体的循环特征
J Endocrinol Invest. 2008 Feb;31(2):163-8. doi: 10.1007/BF03345584.
7
Upregulated Cellular Expression of IL-17 by CD4+ T-Cells in Osteoporotic Postmenopausal Women.绝经后骨质疏松症女性中CD4 + T细胞导致白细胞介素-17细胞表达上调
Ann Nutr Metab. 2016;68(2):113-8. doi: 10.1159/000443531. Epub 2016 Jan 16.
8
The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis.可溶性受体调节白介素 6 转导信号的平衡可预测绝经后类风湿关节炎患者的 RANKL/骨保护素比值。
Rheumatol Int. 2012 Jan;32(1):199-206. doi: 10.1007/s00296-010-1606-z. Epub 2010 Sep 7.
9
Investigating subtle kidney injury in primary hyperparathyroidism by means of sensitive and specific biomarkers.探讨原发性甲状旁腺功能亢进症中敏感且特异的生物标志物对隐匿性肾损伤的作用。
Clin Endocrinol (Oxf). 2019 Nov;91(5):660-668. doi: 10.1111/cen.14064. Epub 2019 Aug 1.
10
Gingival crevicular fluid, serum levels of receptor activator of nuclear factor-κB ligand, osteoprotegerin, and interleukin-17 in patients with rheumatoid arthritis and osteoporosis and with periodontal disease.龈沟液、核因子-κB 配体受体激活剂、骨保护素和白细胞介素-17 在类风湿关节炎和骨质疏松症伴牙周病患者中的水平。
J Periodontol. 2013 Nov;84(11):1627-37. doi: 10.1902/jop.2013.120595. Epub 2013 Jan 17.

引用本文的文献

1
Unravelling the link between chronic inflammation and primary hyperparathyroidism: a systematic review.揭示慢性炎症与原发性甲状旁腺功能亢进之间的联系:一项系统综述
Front Immunol. 2025 Jun 2;16:1563967. doi: 10.3389/fimmu.2025.1563967. eCollection 2025.
2
Clinical Data for Parametrization of Bone Models Incorporating Cell-Cytokine Dynamics: A Systematic Review of Literature.纳入细胞-细胞因子动力学的骨模型参数化临床数据:文献系统评价
Front Bioeng Biotechnol. 2022 Jul 12;10:901720. doi: 10.3389/fbioe.2022.901720. eCollection 2022.

本文引用的文献

1
The Autophagy in Osteoimmonology: Self-Eating, Maintenance, and Beyond.骨免疫学中的自噬:自我吞噬、维持及其他
Front Endocrinol (Lausanne). 2019 Jul 23;10:490. doi: 10.3389/fendo.2019.00490. eCollection 2019.
2
Osteoporosis: Current and Emerging Therapies Targeted to Immunological Checkpoints.骨质疏松症:针对免疫检查点的现有和新兴治疗方法。
Curr Med Chem. 2020;27(37):6356-6372. doi: 10.2174/0929867326666190730113123.
3
Updates on Osteoimmunology: What's New on the Cross-Talk Between Bone and Immune System.骨免疫学的最新进展:骨骼与免疫系统相互作用的新动态
Front Endocrinol (Lausanne). 2019 Apr 18;10:236. doi: 10.3389/fendo.2019.00236. eCollection 2019.
4
Interleukin-33 serum levels in postmenopausal women with osteoporosis.绝经后骨质疏松症患者血清白细胞介素-33 水平。
Sci Rep. 2019 Mar 7;9(1):3786. doi: 10.1038/s41598-019-40212-6.
5
IL-17 Receptor Signaling in Osteoblasts/Osteocytes Mediates PTH-Induced Bone Loss and Enhances Osteocytic RANKL Production.破骨细胞/骨细胞中的白介素-17 受体信号转导介导甲状旁腺激素诱导的骨丢失,并增强骨细胞核因子-κB 受体激活配体的产生。
J Bone Miner Res. 2019 Feb;34(2):349-360. doi: 10.1002/jbmr.3600. Epub 2018 Nov 6.
6
Parathyroid Diseases and T Cells.甲状旁腺疾病与T细胞
Curr Osteoporos Rep. 2017 Jun;15(3):135-141. doi: 10.1007/s11914-017-0359-y.
7
Characterization of IL-17AA and IL-17FF in rheumatoid arthritis and multiple sclerosis.类风湿关节炎和多发性硬化症中IL-17AA和IL-17FF的特征分析
Bioanalysis. 2016 Nov;8(22):2317-2327. doi: 10.4155/bio-2016-0207. Epub 2016 Sep 13.
8
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.司库奇尤单抗,一种白细胞介素-17A 抑制剂,治疗强直性脊柱炎。
N Engl J Med. 2015 Dec 24;373(26):2534-48. doi: 10.1056/NEJMoa1505066.
9
IL-17A Is Increased in Humans with Primary Hyperparathyroidism and Mediates PTH-Induced Bone Loss in Mice.白细胞介素-17A在原发性甲状旁腺功能亢进患者中升高,并介导甲状旁腺激素诱导的小鼠骨质流失。
Cell Metab. 2015 Nov 3;22(5):799-810. doi: 10.1016/j.cmet.2015.09.012. Epub 2015 Oct 8.
10
IL-17A-mediated sRANK ligand elevation involved in postmenopausal osteoporosis.白细胞介素-17A介导的可溶性核因子κB受体活化因子配体升高与绝经后骨质疏松症有关。
Osteoporos Int. 2014 Feb;25(2):783-6. doi: 10.1007/s00198-013-2548-6. Epub 2013 Dec 13.